Furthermore, because these minority populations are not significantly represented in major clinical trials, evidence-based management strategies for treatment and prevention of CVD are seriously lacking.
However, several randomized trials of therapy for dyslipidemia to reduce cardiovascular events among these ethnic groups have been undertaken.